SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0001193125-13-343822
Filing Date
2013-08-22
Accepted
2013-08-22 16:04:34
Documents
4
Group Members
RENATE SCHULERSCHULER FAMILY FOUNDATIONTANYA EVA SCHULER TRUSTTHERESE HEIDI SCHULER TRUSTTINO HANS SCHULER TRUST

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13D AMENDMENT NO. 1 d586293dsc13da.htm SC 13D/A 159969
2 EX-99.1 d586293dex991.htm EX-99.1 7257
3 EX-99.2 d586293dex992.htm EX-99.2 161714
4 EX-99.3 d586293dex993.htm EX-99.3 62237
  Complete submission text file 0001193125-13-343822.txt   392611
Mailing Address 28161 N. KEITH DRIVE LAKE FOREST IL 60045
Business Address
SCHULER JACK W (Filed by) CIK: 0001021412 (see all company filings)

Type: SC 13D/A

Mailing Address 101 COLLEGE STREET SUITE 220 TORONTO A6 M5G 1L7
Business Address 101 COLLEGE STREET SUITE 220 TORONTO A6 M5G 1L7 416-260-7770
Transition Therapeutics Inc. (Subject) CIK: 0001399250 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 0630
Type: SC 13D/A | Act: 34 | File No.: 005-83093 | Film No.: 131055353
SIC: 2833 Medicinal Chemicals & Botanical Products